isopropyl 4-[6-(4-{[(2-fluoroethyl)carbamoyl]amino}phenyl)-4-morpholin-4-yl-1Hpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate

ID: ALA1094981

PubChem CID: 44605426

Max Phase: Preclinical

Molecular Formula: C27H35FN8O4

Molecular Weight: 554.63

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NCCF)cc4)nc32)CC1

Standard InChI:  InChI=1S/C27H35FN8O4/c1-18(2)40-27(38)35-11-7-21(8-12-35)36-25-22(17-30-36)24(34-13-15-39-16-14-34)32-23(33-25)19-3-5-20(6-4-19)31-26(37)29-10-9-28/h3-6,17-18,21H,7-16H2,1-2H3,(H2,29,31,37)

Standard InChI Key:  WQJYOLLPRXNMCU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 40 44  0  0  0  0  0  0  0  0999 V2000
    1.1902   -0.1541    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1891   -0.9815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9039   -1.3944    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9021    0.2586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6175   -0.1505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6224   -0.9815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4142   -1.2337    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8988   -0.5585    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4063    0.1109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4762   -1.3937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2382   -0.9789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2345   -2.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4769   -2.2153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8996    1.0836    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6108    1.4953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6103    2.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8965    2.7309    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1814    2.3175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1802    1.4899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8208   -1.9458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4045   -2.6536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8104   -3.3652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6313   -3.3695    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0446   -2.6563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6363   -1.9476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9536   -2.2161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9554   -1.3920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0414   -4.0854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6672   -2.6302    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3826   -2.2193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3845   -1.3943    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0961   -2.6335    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8115   -2.2226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6264   -4.7985    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8664   -4.0883    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2764   -4.8041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5250   -2.6367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2405   -2.2259    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.1014   -4.8070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8614   -5.5172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
  9  5  1  0
  7 20  1  0
  4  1  1  0
 20 21  1  0
  5  6  1  0
 21 22  1  0
 10 11  2  0
 22 23  1  0
 11 27  1  0
 23 24  1  0
 24 25  1  0
 25 20  1  0
 26 27  2  0
 26 12  1  0
  2  3  1  0
 12 13  2  0
 23 28  1  0
 13 10  1  0
 26 29  1  0
  2 10  1  0
 29 30  1  0
  3  6  2  0
 30 31  2  0
  4 14  1  0
 30 32  1  0
 14 15  1  0
 32 33  1  0
  1  2  2  0
 28 34  2  0
  5  4  2  0
 28 35  1  0
  6  7  1  0
 35 36  1  0
  7  8  1  0
 33 37  1  0
  8  9  2  0
 37 38  1  0
 14 19  1  0
 36 39  1  0
 15 16  1  0
 36 40  1  0
M  END

Associated Targets(Human)

CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CG Tclin PI3-kinase p110-gamma subunit (5411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATR Tchem Serine-protein kinase ATR (986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 554.63Molecular Weight (Monoisotopic): 554.2765AlogP: 3.60#Rotatable Bonds: 7
Polar Surface Area: 126.74Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.01CX Basic pKa: 4.01CX LogP: 2.92CX LogD: 2.92
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.45Np Likeness Score: -2.00

References

1. Verheijen JC, Richard DJ, Curran K, Kaplan J, Lefever M, Nowak P, Malwitz DJ, Brooijmans N, Toral-Barza L, Zhang WG, Lucas J, Hollander I, Ayral-Kaloustian S, Mansour TS, Yu K, Zask A..  (2009)  Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent.,  52  (24): [PMID:19894727] [10.1021/jm9013828]

Source